The week at Retraction Watch featured news of a fine for a doctor who took part in a controversial fake trial, and a likely unprecedented call for retraction by the U.S. FDA commissioner. Here’s what was happening elsewhere:
The head of the U.S. Food and Drug Administration (FDA) has called for the retraction of a study about a drug that the agency itself approved earlier this week, despite senior staff opposing the approval. On September 19, the FDA okayed eteplirsen to treat Duchenne muscular dystrophy (DMD), a rare genetic disorder that results in muscle degeneration and … Continue reading Amid controversial Sarepta approval decision, FDA head calls for key study retraction
The week at Retraction Watch featured a look at whether we have an epidemic of flawed meta-analyses, and the story of a strange case involving climate research and pseudonyms. Here’s what was happening elsewhere:
Recently, we reported that social psychologist and renowned data faker Diederik Stapel had found himself a new gig supporting research at a vocational university in the Netherlands — but it appears that was short-lived. According to multiple news reports, NHTV Breda will not be employing Stapel, after all. Here’s our Google translate of a portion from … Continue reading No academic post for fraudster Diederik Stapel, after all
Institutions in France and Switzerland are investigating figures in several molecular biology papers, according to a joint press release published today. Unfortunately, there’s not much more we can tell you about the investigation — the press release doesn’t specify the names of researchers, journals, or even the area within molecular biology that’s under scrutiny. The National … Continue reading Swiss, French institutions investigating several papers
It’s not often that a paper elicits an apology — but that’s just what happened when family members first learned a bagpipe musician died from inhaling mold and fungi from a case study reported in a journal. The hospital has since apologized; the journal, however, told us it is not planning to issue a retraction. The … Continue reading Despite apology, bagpipes study not slated for retraction
The week at Retraction Watch featured health care fraud charges for a researcher who committed scientific fraud, and a first-ever government agency lawsuit against a scientific publisher for deceit. Here’s what was happening elsewhere:
The U.S. Federal Trade Commission has charged a publisher of hundreds of academic journals with deceiving readers about reviewing practices, publication fees, and the nature of its editorial boards. Here’s more from a news release about the suit:
The week at Retraction Watch featured an inscrutable retraction notice, and a raft of new retractions for a cancer researcher who once threatened to sue us. Here’s what was happening elsewhere:
The week at Retraction Watch featured a first in transparency from Canada, and the second retraction for a fan of a conspiracy theory. Here’s what was happening elsewhere: